Difference between revisions of "Workshop INTA on ACTA"

From La Quadrature du Net
Jump to navigationJump to search
m (Location)
m (Time)
Line 15: Line 15:
Thursday, 1 March 2012
Thursday, 1 March 2012<br/>
From 15.00 to 18.30
From 15.00 to 18.30

Revision as of 17:14, 14 February 2012

On March 1st, 2012, the European Parliament's "INTA" committee holds a public workshop on ACTA.
This page give all the information on this meeting.
See our dossier on ACTA, a list of NGOs, politicians, academics, etc. against ACTA, counter-arguments to answer those defending ACTA, and a 2 minute video on ACTA.
To be informed about the next steps to urge Members of the European Parliament to reject ACTA, send a blank email to NOtoACTA-subscribe@laquadrature.net to subscribe to our list.
To discuss ACTA, subscribe to our discussion list by sending a blank email to acta-subscribe@laquadrature.net. We won't use your email for anything else.

Practical information


European Parliament
Paul-Henri Spaak Building
Room P3C050


Thursday, 1 March 2012
From 15.00 to 18.30


15:00 : Welcome and introduction to the workshop by INTA Chairman Prof. Vital MOREIRA

Panel 1

15:15: A comprehensive assessment of the “Anti-Counterfeiting Trade Agreement” (ACTA) and the EU IPR protection and enforcement-related trade policies.
Speakers: Mr Karel DE GUCHT (EU Commissioner for Trade), Dr Michael GEIST (University of Ottawa), Prof. Christophe GEIGER (University of Strasbourg)

Panel 2

16.15: Presentation of the European Parliament’s External Study entitled “The Anti-Counterfeiting Trade Agreement” (Policy Department, 2011)
Speakers: Prof. Anselm Kamperman SANDERS (Maastricht University) Prof. Dalindyebo SHABALALA (Maastricht University)

The presentation will be followed by comments from the European Commission represented by Mr Pedro VELASCO MARTINS, Deputy Head of Unit, DG TRADE

Panel 3

17.15: Specific aspects of ACTA The EU acquis and ACTA: Are civil liberties under threat? - What will be the likely impact of ACTA on EU Member States’ national legislation on IPR enforcement?
Speakers: Dr Olivier VRINS (ALTIUS Lawyers), Mr Rupert SCHLEGELMILCH (EC, Director, DG TRADE) or Mr Anders JESSEN (EC, Head of Unit, DG TRADE)
Is ACTA likely to restrict access to medicines in developing countries? Is ACTA a potential danger for trade in generic drugs? Speakers: Dr Meir PUGATCH (University of Haifa), Mr Rupert SCHLEGELMILCH (EC, Director, DG TRADE) or Mr Anders JESSEN (EC, Head of Unit, DG TRADE)

18.15 Concluding remarks by INTA rapporteur 18.25 Closure of the workshop by INTA Chairman Prof. Vital MOREIRA